Product Information

DOXEPIN 100 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2669 per EA under NDC 59651017701. Its NADAC has been published 366 times since Aug 21, 2019.

FDA first approved this application on Mar 27, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DOXEPIN 100 MG CAPSULE

Doxepin Hydrochloride
$0.2669per EA

Strength

100 mg/1

NDC

59651017701

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DOXEPIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA211603

FDA Approved

3/27/2019

TE Code

AB

On Market Since

3/27/2019

Pharmacological Classes

Price Statistics

The NADAC for DOXEPIN 100 MG CAPSULE has been published 366 times since Aug 21, 2019, and over the history we have for it it has declined 72.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2669 per EA
All-time high$1.1152 (Feb 12, 2020)
All-time low$0.2255 (Feb 19, 2025)
52-week high$0.2936
52-week low$0.2324
Median price$0.4473
Average price$0.5196
Largest weekly change+46.8% (Aug 21, 2024)
Weeks tracked366
Tracking sinceAug 21, 2019

Price History

1W

+1.2%

1M

+1.2%

3M

+0.9%

6M

-4.0%

1Y

+1.8%

3Y

-40.3%

5Y

-61.7%

All

-72.2%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DOXEPIN 100 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN 100 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.2669 per EA (NDC 59651017701), effective Aug 19, 2026.

How has the price of DOXEPIN 100 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for DOXEPIN 100 MG CAPSULE has declined 72.2%. It has been tracked across 366 weekly CMS publications since Aug 21, 2019.

What are the highest and lowest recorded NADAC prices for DOXEPIN 100 MG CAPSULE?

Since Aug 21, 2019, the NADAC for DOXEPIN 100 MG CAPSULE has ranged from a low of $0.2255 (Feb 19, 2025) to a high of $1.1152 (Feb 12, 2020), with a median of $0.4473 per EA.

Are there cheaper alternatives to DOXEPIN 100 MG CAPSULE?

7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DOXEPIN 100 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures DOXEPIN 100 MG CAPSULE?

DOXEPIN 100 MG CAPSULE (NDC 59651017701) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.